Company
Company
Our Mission
Leadership
Pipeline
Technology
Quantum Engine™
GTailor™
Quantum Nufect™
Quantum pBac™
iCellar™
qCART™
Protein / Target Hunter
Clinical trial
Partnership
Media
Events & Presentations
Publications
Careers
Contact Us
English
繁體中文
✕
EVENTS & PRESENTATIONS
Events
GenomeFrontier Awarded $100,000 G-Rex® Grant to Advance Non-Viral CAR T Cell Therapy, GF-CART01
Read more
GenomeFrontier Presents at the 10th Annual CAR-TCR Summit
Read more
GenomeFrontier Presents the 2025 Antibody Therapeutic & The 20th Frontiers in Biomedical Sciences Conference
Read more
Taiwan FDA clears GenomeFrontier’s IND application for GF-CART01, a CD20/CD19 dual targeting CAR T cell therapy for hematological B cell malignancies!
Read more
Our Founder/CEO/CSO, Sareina Wu, and our Director of Scientific communication, Marcus J. Calkins, will present our work as invited expert speakers at the 9th Annual CAR-TCR Summit in Boston, US. (September 17-20, 2024)
Read more
Prev page
1
2
3
4
...
8
Next page
